Ondřej Dammer

Dr. Ondřej Dammer


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MŠMarek Šoltys
Marek Šoltys
PKPavel Kovačík
Pavel Kovačík
ODOndřej Dammer
Ondřej Dammer
JBJosef Beránek
Josef Beránek
FŠFrantišek Štěpánek
František Štěpánek

23 April 2009 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
ODOndřej Dammer
Ondřej Dammer
BVBlanka Vlčková
Blanka Vlčková
MPMarek Procházka
Marek Procházka
JSJan Sedláček
Jan Sedláček
JVJiri Vohlídal
Jiri Vohlídal
Jiří PflegerJiří Pfleger
Jiří Pfleger
The influence of the poly(N-ethyl-2-ethynylpyridinium iodide) (PEEP-I) concentration on the morphology and optical properties of nanocomposite systems prepared by mixing the polymer solution with a hydrosol of ca. 9 nm Ag nanoparticles (NPs) was investigated by a combination of surface plasmon extinction (SPE) measurements, transmission electron microscope (TEM) imaging and surface-enhanced Raman spectroscopy (SERS). The PEEP-I concentration was found to have a strong impact on the assembly of Ag NPs and, consequently, on the optical responses of the composite systems. At low polymer concentrations in the composite (corresponding to ca. 50–1800 monomer units/NP), the formation of fractal aggregates was observed. In particular, the average fractal dimension D = 1.9 ± 0.1 was determined for aggregates in the system with 5 × 10−6 M polymer concentration. By contrast, in systems with polymer concentrations higher than about 1 × 10−5 M, relatively small aggregates of Ag NPs with large interparticle distances were formed. The differences in the morphology of the composite systems with various polymer concentrations manifested themselves clearly in their SPE spectra. Furthermore, upon optical excitation with appropriate wavelengths (488.0 and 514.5 nm), the fractal aggregates acted as carriers of “hot spots”, i.e. strong, localized, nanoscale optical fields, from which intense and well resolved SERS spectra of the polymer were obtained.

6 August 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RCRicardo Machado Cruz
Ricardo Machado Cruz
TBTereza Boleslavská
Tereza Boleslavská
JBJosef Beranek
Josef Beranek
ETEszter Tieger
Eszter Tieger
BTBrendan Twamley
Brendan Twamley
Lidia TajberLidia Tajber
Lidia Tajber
The crystallization of poorly soluble drug molecules with an excipient into new solid phases called cocrystals has gained a considerable popularity in the pharmaceutical field. In this work, the cocrystal approach was explored for a very poorly water soluble antifungal active, itraconazole (ITR), which was, for the first time, successfully converted into this multicomponent solid using an aromatic coformer, terephthalic acid (TER). The new cocrystal was characterized in terms of its solid-state and structural properties, and a panel of pharmaceutical tests including wettability and dissolution were performed. Evidence of the cocrystal formation was obtained from liquid-assisted grinding, but not neat grinding. An efficient method of the ITR–TER cocrystal formation was ball milling. The stoichiometry of the ITR–TER phase was 2:1 and the structure was stabilized by H-bonds. When comparing ITR–TER with other cocrystals, the intrinsic dissolution rates and powder dissolution profiles correlated with the aqueous solubility of the coformers. The rank order of the dissolution rates of the active pharmaceutical ingredient (API) from the cocrystals was ITR–oxalic acid > ITR–succinic acid > ITR–TER. Additionally, the ITR–TER cocrystal was stable in aqueous conditions and did not transform to the parent drug. In summary, this work presents another cocrystal of ITR that might be of use in pharmaceutical formulations.

6 January 2017 in Crystals
Verified
Journal Article
Open access
PDF file
VSVeronika Sladkova
Veronika Sladkova
ODOndřej Dammer
Ondřej Dammer
GSGregor Sedmak
Gregor Sedmak
ESEliška Skořepová
Eliška Skořepová
BKBohumil Kratochvíl
Bohumil Kratochvíl
The pharmaceutical salt ivabradine hydrochloride is indicated for the symptomatic treatment of chronic stable angina pectoris and chronic heart failure. It exhibits extensive polymorphism and co-crystallization, which could be a way to provide an alternative solid form. We conducted a co-crystal screen, from which two hits were identified: with (S)-mandelic and (R)-mandelic acid. Both structures were determined from single-crystal X-ray diffraction data as co-crystals. The co-crystals were further characterized by common solid-state techniques, such as X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), solid-state NMR, IR and Raman spectroscopy, and dynamic vapor sorption (DVS). The co-crystal with (S)-mandelic acid was selected for further development; its physical and chemical stability was compared with two different polymorphs of the hydrochloride salt. The co-crystal exhibited a similar stability with the polymorph used in the original drug product and was, therefore, selected for formulation into the drug product. During the pre-formulation experiments, the in situ formation of the co-crystal was achieved during the wet granulation process. The following formulation experiments showed no influence of in situ prepared co-crystal on the overall stability of the bulk, when compared with pre-prepared co-crystal formulation.

17 December 2015 in Organic Process Research & Development
Verified
Journal Article
Closed access
JHJan Holaň
Jan Holaň
ESEliška Skořepová
Eliška Skořepová
LHLea Heraud
Lea Heraud
DBDavid Baltes
David Baltes
JRJan Rohlicek
Jan Rohlicek
FŠFrantišek Štěpánek
František Štěpánek

1 November 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
JTJan Tomas
Jan Tomas
MSMarek Schöngut
Marek Schöngut
ODOndřej Dammer
Ondřej Dammer
JBJosef Beránek
Josef Beránek
AZAleš Zadražil
Aleš Zadražil
FŠFrantišek Štěpánek
František Štěpánek